Chesapeake Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,816
Closed -$233K 168
2022
Q1
$233K Sell
1,816
-600
-25% -$65.6K 0.08% 173
2021
Q4
$324K Sell
2,416
-172
-7% -$24.7K 0.11% 155
2021
Q3
$354K Sell
2,588
-1,216
-32% -$153K 0.13% 146
2021
Q2
$406K Sell
3,804
-3,724
-49% -$358K 0.13% 152
2021
Q1
$676K Buy
7,528
+808
+12% +$75.8K 0.23% 101
2020
Q4
$622K Buy
6,720
+2,624
+64% +$234K 0.21% 110
2020
Q3
$422K Buy
+4,096
New +$428K 0.16% 134

Other funds holding DXCM

Chesapeake Wealth Management's DXCM Position: Q2 2022 in Review

Chesapeake Wealth Management sold out of DexCom (DXCM) in Q2 2022, closing a stake of 1,816 shares — an estimated $233K sold.

Chesapeake Wealth Management first reported a position in DXCM in Q3 2020 and held it in 7 quarters. The position peaked at $676K in Q1 2021. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Chesapeake Wealth Management reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Chesapeake Wealth Management sold 1,816 DexCom shares in Q2 2022, an estimated $233K.
  • Chesapeake Wealth Management first reported a position in DexCom in Q3 2020 and held it in 7 quarters.
  • Chesapeake Wealth Management's DexCom position peaked at $676K in Q1 2021.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Chesapeake Wealth Management's 13F filing for Q2 2022, filed 21 Jul 2022.